Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantation.
<h4>Background</h4>Given the limited efficacy and high adverse event rate associated with treatment of recurrent hepatitis C after liver transplantation, an individualized treatment strategy should be considered. The aim of this study was to identify predictors of response to antiviral t...
| Հիմնական հեղինակներ: | , , , , , , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
Public Library of Science (PLoS)
2013-01-01
|
| Շարք: | PLoS ONE |
| Առցանց հասանելիություն: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23505497/?tool=EBI |